What is the equity of Nkarta this year?
Nkarta has equity of 273.29 M USD this year.
Nkarta Equity 2024
Nkarta Equity
273.29 M USD
Ticker
NKTX
ISIN
US65487U1088
WKN
A2P797
In 2024, Nkarta's equity was 273.29 M USD, a -26.58% increase from the 372.2 M USD equity in the previous year.
Nkarta Aktienanalyse
What does Nkarta do?
Nkarta Inc is a biopharmaceutical company based in South San Francisco, California. The company was founded in 2015 by Dr. Raphael Rousseau (CEO) to develop a groundbreaking new therapy for cancer patients. The business model of Nkarta is based on the development of novel CAR-T cell therapies. These are a special type of immunotherapy in which the patient's own immune cells are genetically modified and used to target tumor cells. Unlike conventional chemotherapy or radiation, which can also attack healthy cells, CAR-T cell therapies specifically target cancer cells while sparing the surrounding healthy tissue. Nkarta is divided into various business areas, including research and development of new therapies, manufacturing and production of CAR-T cells, and clinical trials and approval processes for broad application. One of Nkarta's key products is NKR-2, a CAR-T cell therapy based on natural killer cells. These cells have high activity against cancer cells and can respond quickly to threats. NKR-2 differentiates itself from other therapies by its ability to be effective even at low concentrations. This means that fewer cells are needed and the risk of unwanted side effects is reduced. Nkarta is also working on other projects, including NKX101, which specializes in treating solid tumors, and Voretigene Neparvovec, a gene therapy for the rare hereditary retinal disease. In 2020, Nkarta entered into a partnership with CRISPR Therapeutics to explore the joint potential of CRISPR gene editing and CAR-T cell therapy. The collaboration aims to improve the precision and effectiveness of CAR-T cell therapies and ultimately increase the chances of a cure for cancer patients. Overall, Nkarta has had an impressive success story in recent years. The company has raised several million dollars in funding and continues to expand. The groundbreaking technology of CAR-T cell therapies is promising and has the potential to have a sustainable impact on healthcare. With Nkarta at the forefront, the future could look much more hopeful for cancer patients. Nkarta ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Nkarta's Equity
Nkarta's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Nkarta's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Nkarta's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Nkarta's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Nkarta’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Nkarta stock
What was the equity of Nkarta compared to the previous year?
The equity of Nkarta has increased/decreased by -26.58% decreased compared to the previous year.
What impact does a high equity have on investors of Nkarta?
A high equity is advantageous for investors of Nkarta as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Nkarta?
A low equity can be a risk for investors of Nkarta, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Nkarta affect the company?
An increase in equity of Nkarta can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Nkarta affect the company?
A reduction in equity of Nkarta can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Nkarta?
Some factors that can affect the equity of Nkarta include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Nkarta so important for investors?
The equity of Nkarta is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Nkarta take to change the equity?
To change equity, Nkarta can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Nkarta pay?
Over the past 12 months, Nkarta paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nkarta is expected to pay a dividend of 0 USD.
What is the dividend yield of Nkarta?
The current dividend yield of Nkarta is .
When does Nkarta pay dividends?
Nkarta pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Nkarta?
Nkarta paid dividends every year for the past 0 years.
What is the dividend of Nkarta?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Nkarta located?
Nkarta is assigned to the 'Health' sector.
Wann musste ich die Aktien von Nkarta kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Nkarta from 12/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/3/2024.
When did Nkarta pay the last dividend?
The last dividend was paid out on 12/3/2024.
What was the dividend of Nkarta in the year 2023?
In the year 2023, Nkarta distributed 0 USD as dividends.
In which currency does Nkarta pay out the dividend?
The dividends of Nkarta are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Nkarta
Our stock analysis for Nkarta Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nkarta Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
